Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Accreditation | 6 | 2016 | 19 | 2.010 |
Why?
|
| Education, Medical | 7 | 2016 | 104 | 1.930 |
Why?
|
| Curriculum | 6 | 2016 | 265 | 1.710 |
Why?
|
| Schools, Medical | 9 | 2016 | 198 | 1.580 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2012 | 80 | 0.810 |
Why?
|
| Amino Acid Oxidoreductases | 3 | 2012 | 35 | 0.740 |
Why?
|
| Clinical Clerkship | 2 | 2016 | 24 | 0.640 |
Why?
|
| Educational Measurement | 2 | 2015 | 86 | 0.540 |
Why?
|
| Protein-Lysine 6-Oxidase | 6 | 2012 | 67 | 0.360 |
Why?
|
| Mammary Glands, Human | 2 | 2009 | 39 | 0.350 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 219 | 0.310 |
Why?
|
| Research | 1 | 2009 | 163 | 0.300 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 127 | 0.270 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 186 | 0.250 |
Why?
|
| Breast Neoplasms | 4 | 2009 | 1502 | 0.250 |
Why?
|
| Cell Differentiation | 2 | 2007 | 587 | 0.250 |
Why?
|
| Students, Medical | 3 | 2016 | 130 | 0.190 |
Why?
|
| Humans | 16 | 2016 | 37093 | 0.180 |
Why?
|
| Faculty, Medical | 2 | 2016 | 66 | 0.170 |
Why?
|
| Azacitidine | 2 | 2009 | 22 | 0.160 |
Why?
|
| Hawaii | 4 | 2015 | 1929 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 893 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 623 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 168 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2009 | 859 | 0.140 |
Why?
|
| Cell Line | 3 | 2009 | 1354 | 0.130 |
Why?
|
| Career Choice | 1 | 2016 | 45 | 0.130 |
Why?
|
| Counseling | 1 | 2016 | 116 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 2012 | 115 | 0.120 |
Why?
|
| Aorta, Abdominal | 1 | 2012 | 9 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 17 | 0.110 |
Why?
|
| Physician-Nurse Relations | 1 | 2012 | 3 | 0.110 |
Why?
|
| Education, Nursing | 1 | 2012 | 14 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 36 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 67 | 0.100 |
Why?
|
| Catalysis | 2 | 2009 | 179 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2012 | 138 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2012 | 134 | 0.090 |
Why?
|
| Loss of Heterozygosity | 2 | 2007 | 19 | 0.090 |
Why?
|
| Integrins | 1 | 2009 | 51 | 0.090 |
Why?
|
| DNA Primers | 2 | 2007 | 286 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 32 | 0.090 |
Why?
|
| Aminopropionitrile | 4 | 2012 | 13 | 0.070 |
Why?
|
| CpG Islands | 1 | 2007 | 97 | 0.070 |
Why?
|
| Cell Movement | 2 | 2005 | 571 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 190 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2005 | 212 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 515 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 286 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2231 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2002 | 10 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 807 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 2379 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 251 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 661 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2012 | 1207 | 0.040 |
Why?
|
| Aged | 2 | 2007 | 6741 | 0.040 |
Why?
|
| Mutation | 1 | 2002 | 1095 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2016 | 22 | 0.040 |
Why?
|
| Collagen | 2 | 2009 | 172 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2016 | 29 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 441 | 0.030 |
Why?
|
| Female | 4 | 2009 | 20969 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2005 | 251 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2005 | 502 | 0.030 |
Why?
|
| Middle Aged | 1 | 2007 | 10129 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 41 | 0.030 |
Why?
|
| Preceptorship | 1 | 2012 | 9 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2012 | 54 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2012 | 97 | 0.030 |
Why?
|
| Adult | 1 | 2007 | 11712 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 129 | 0.020 |
Why?
|
| Male | 2 | 2007 | 20025 | 0.020 |
Why?
|
| Mice | 2 | 2012 | 5913 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 25 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 68 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 933 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 159 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2009 | 1908 | 0.020 |
Why?
|
| Animals | 3 | 2012 | 15081 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1609 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1371 | 0.020 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2005 | 9 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 19 | 0.020 |
Why?
|
| Euchromatin | 1 | 2005 | 6 | 0.020 |
Why?
|
| Catalase | 1 | 2005 | 109 | 0.020 |
Why?
|
| Salivary Glands | 1 | 2005 | 12 | 0.020 |
Why?
|
| Elastin | 1 | 2005 | 40 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 59 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 58 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 99 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 664 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2005 | 128 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 188 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2005 | 143 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 191 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 269 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 172 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2005 | 444 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 218 | 0.020 |
Why?
|
| Genome | 1 | 2005 | 125 | 0.020 |
Why?
|
| Saliva | 1 | 2005 | 107 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 408 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 169 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 515 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 180 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 435 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 381 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 39 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 12 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1180 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2002 | 69 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 578 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 59 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 93 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1568 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2002 | 161 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2002 | 87 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 523 | 0.010 |
Why?
|
| Colon | 1 | 2002 | 103 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 433 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 513 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 1492 | 0.010 |
Why?
|